The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
New devices for Hospital Sant Joan de Déu
In 2014 and 2015, i4c has kept its collaboration with Hospital Sant Joan de Deu by purchasing a new device for induced hypothermia EUR16,000 worth. Besides, i 2015 i4c has…
see project